Recalibrating the risks and benefits of lithium therapy

Michael Berk, Stephanie Cowdery, Lana J. Williams, Gin S Malhi

Research output: Contribution to journalEditorialResearchpeer-review

7 Citations (Scopus)


Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalBritish Journal of Psychiatry
Issue number1
Publication statusPublished - 1 Jul 2017
Externally publishedYes

Cite this